Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use) (NCT06393660) | Clinical Trial Compass
AVAILABLENot Applicable
Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)
United States
Plain-language summary
The protocol is designed to provide access to patients to the Clinimacs® CD34 TCRαβ system to prepare cells for an unlabeled indication using an HLA-compatible related or unrelated donor for allogenic transplant.
Who can participate
Age range21 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Recipient Inclusion Criteria:
* Age less than 22 years of age
* No available genotypically matched related donor (sibling)
* Availability of a suitable donor and graft source
* Haploidentical related mobilized peripheral blood cells
* 9/10 or 10/10 allele matched (HLA-A, -B, -C, -DRB1, -DQB1) volunteer unrelated donor mobilized peripheral blood cells
Donor Inclusion Criteria:
* Matching as described in the Recipient and Donor Suitability Criteria
* Size and vascular access appropriate by center standard for peripheral blood stem cell (PBSC) collection. Donors with inadequate peripheral access will require placement of an apheresis catheter for collection.
* Must meet appropriate screening/eligibility requirements:
* Haploidentical matched family members: screened by center health screens and found to be eligible.
* Unrelated donors: meet suitability criteria to donate PBSC
* HIV negative
* Not pregnant or lactating
* Recipient must not have high-level donor specific anti-HLA antibodies according to institutional practices.
* Must agree to donate PBSC
* Must give informed consent
Recipient Suitability:
\- Adequate organ functioning as demonstrated by:
* MUGA ≥ 50% or ECHO \>30%
* 24-hour Creatinine Clearance or Glofil ≥ 50 ml/min or Serum Creatinine ≤2 times the upper limit of normal
* DLCO \> 65% of predicted value. FEV1 \>65% of predicted
* AST / ALT ≤ 2.5 and/or Bilirubin ≤ 1.5 times the upper limit of normal
* Pregnancy test negative
* HIV 1 /…